Design Therapeutics, Inc.
Design Therapeutics, Inc. a preclinical-stage biopharmaceutical company, engages in the development of therapies for the treatment of genetic diseases caused by nucleotide repeat expansions. The company's portfolio of products comprises Friedreich Ataxia…
Biotechnology
US, Carlsbad [HQ]
Strategy & Leadership
Mergers & Acquisitions Beta
M&As
M&A Deals · Breakdown
Design Therapeutics, Inc. has no acquisition track records yet.
M&A Deals · History
Design Therapeutics, Inc. has no acquisition track records yet.